Evidence map›Paper›PMID 35277403›Full record

Observational studyBMJ open2022

Clinical profile, risk factors and outcomes of ric COVID-19: a retrospective cohort multicentre study in Saudi Arabia.

Waleed H Albuali, Amal A AlGhamdi, Shaikha J Aldossary, Saleh A AlHarbi, Sami I Al Majed, Ahmed Alenizi, Mohammad H Al-Qahtani, Amer A Lardhi, Shams A Al-Turki, Abdulaziz S AlSanea and 9 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Waleed H AlbualiDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Amal A AlGhamdiDepartment of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Shaikha J AldossaryDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Saleh A AlHarbiDepartment of Pediatrics, Umm Al-Qura University, Makkah, Saudi Arabia.
Sami I Al MajedDepartment of Pediatrics, John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Ahmed AleniziPediatric Pulmonology and Sleep Medicine Department, King Saud Medical City, Riyadh, Saudi Arabia.
Mohammad H Al-QahtaniDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Amer A LardhiDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Shams A Al-TurkiDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Abdulaziz S AlSaneaDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Dalal K BubshaitDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
Sumayyah A KobeisyDepartment of Pediatrics, Dr Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Noor H HerzallahDepartment of Pediatrics, John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Wejdan A AlqarniDepartment of Pediatrics, John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Abeer H AlHarbiPediatric Pulmonology and Sleep Medicine Department, King Saud Medical City, Riyadh, Saudi Arabia.
Hamad W AlbualiCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Bader J AldossaryCollege of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Faisal O AlQurashiDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia faisal.alqurashi@yahoo.com.ORCID 0000-0003-3411-819X
Abdullah A YousefDepartment of Pediatrics, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, AlKhobar, Saudi Arabia.
King Fahd Hospital of the University · SAImam Abdulrahman Bin Faisal University · SASaudi Aramco Medical Services Organization · SAKing Saud Medical City · SASoliman Fakeeh Hospital · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the risk factors, clinical profile and outcomes of COVID-19 in the paediatric population.

designMulticentre, retrospective observational study.

settingFour tertiary hospitals in Saudi Arabia. PATIENTS: We recruited 390 paediatric patients aged 0-18 years who presented from March to December 2020 and tested positive for COVID-19 on PCR.

main outcome measuresWe retrospectively analysed medical records for sociodemographics, health indicators, clinical presentations, laboratory findings, clinical complications, and outcomes.

resultsThe mean participant age was 5.66±4.90 years, and the mean hospital stay was 2.17±3.48 days. Forty patients, mostly school-aged children (16, 40.00%; p=0.005) and children with comorbidities (25, 62.50%; p<0.001), received more than just supportive care. Complications were seen in 15 (3.9%) patients, bacterial infection being the most common (6, 40.00%). Patients presented with dyspnoea (OR 6.89; 95% CI 2.89 to 20.72), abnormal chest radiographs (OR 6.11; 95% CI 1.26 to 29.38), lethargy (OR 9.04; 95% CI 2.91 to 28.06) and elevated ferritin (OR 14.21; 95% CI 4.18 to 48.37) and D-dimer (OR 48.40; 95% CI 14.32 to 163.62), with higher odds of developing complications. The odds of paediatric intensive care unit (ICU) admission were higher for patients with dyspnoea (adjusted OR 4.66; 95% CI 1.24 to 17.50) and elevated white blood cell count (adjusted OR 3.54; 95% CI 1.02 to 12.30).

conclusionsCOVID-19 complications were limited among our patients. However, dyspnoea, abnormal chest radiographs, lethargy and elevated ferritin and D-dimer were associated with an increased risk of complications. Dyspnoea, leucocytosis, comorbidities and abnormal chest radiographs at presentation increased the risk of ICU admission.

Indexed as

COVID-19AdolescentChildChild, PreschoolHospitalizationHumansInfantInfant, NewbornRetrospective StudiesRisk FactorsSaudi ArabiaCOVID-19paediatric intensive & critical carepaediatrics

Identifiers

PMID35277403
PMCPMC8919130
OpenAlexW4220702447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.